Pulmonary Hypertension:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Pulmonary Hypertension Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Pulmonary Hypertension 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Pulmonary Hypertension 23
Subjects Recruited Over a Period of Time 33
Prominent Sponsors 34
Top Companies Participating in Pulmonary Hypertension Therapeutics Clinical Trials 36
Prominent Drug Comparison 38
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
Actelion Ltd 39
Clinical Trial Overview of Actelion Ltd 39
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
United Therapeutics Corporation 48
Clinical Trial Overview of United Therapeutics Corporation 48
Bayer AG 51
Clinical Trial Overview of Bayer AG 51
Gilead Sciences, Inc. 54
Clinical Trial Overview of Gilead Sciences, Inc. 54
GlaxoSmithKline plc 56
Clinical Trial Overview of GlaxoSmithKline plc 56
Novartis AG 58
Clinical Trial Overview of Novartis AG 58
Eli Lilly and Company 59
Clinical Trial Overview of Eli Lilly and Company 59
Lung LLC 60
Clinical Trial Overview of Lung LLC 60
INO Therapeutics, LLC 61
Clinical Trial Overview of INO Therapeutics, LLC 61
Clinical Trial Overview of Top Institutes / Government 62
National Heart, Lung, and Blood Institute 62
Clinical Trial Overview of National Heart, Lung, and Blood Institute 62
The Medical University of Graz 63
Clinical Trial Overview of The Medical University of Graz 63
University of Heidelberg 64
Clinical Trial Overview of University of Heidelberg 64
The Cleveland Clinic 65
Clinical Trial Overview of The Cleveland Clinic 65
Assistance Publique – Hopitaux de Paris 66
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 66
Keio University 67
Clinical Trial Overview of Keio University 67
Stanford University 68
Clinical Trial Overview of Stanford University 68
Imperial College London 69
Clinical Trial Overview of Imperial College London 69
University of California, Los Angeles 70
Clinical Trial Overview of University of California, Los Angeles 70
Eunice Kennedy Shriver National Institute of Child Health and Human Development 71
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 71
Five Key Clinical Profiles 72
Appendix 181
Abbreviations 181
Definitions 181
Research Methodology 182
Secondary Research 182
About GlobalData 182
Contact Us 182
Disclaimer 183
Source 183


【レポート販売概要】

■ タイトル:Pulmonary Hypertension:グローバル臨床試験レビューH2, 2013
■ 英文:Pulmonary Hypertension Global Clinical Trials Review, H2, 2013
■ 発行日:2013年11月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403163027
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。